Table 3 Target prediction and pathway enrichment analysis of hsa-miR-145-5p.
Gene Symbol | Gene Description | miRANDA | miRDB | TargetScan |
|---|---|---|---|---|
ABCE1 | ATP-binding cassette, sub-family E, member 1 | −2.33 | 100 | −0.73 |
ADD3 | adducin 3 | −1.59 | 98 | −0.61 |
ATXN2 | ataxin 2 | −2 | 97 | −0.54 |
DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein | −2.71 | 100 | −0.62 |
EPS15 | epidermal growth factor receptor pathway substrate 15 | −1.55 | 87 | −0.3 |
EXOC8 | exocyst complex component 8 | −1.89 | 93 | −0.6 |
FSCN1 | fascin homolog 1, actin-bundling protein | −1.97 | 97 | −0.97 |
LOX | lysyl oxidase | −2.24 | 97 | −0.34 |
MPZL2 | myelin protein zero-like 2 | −2.36 | 100 | −0.61 |
NAV3 | neuron navigator 3 | −1.99 | 95 | −0.74 |
SEMA3A | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3 A | −1.9 | 99 | −0.65 |
ST6GALNAC3 | ST6(alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | −1.87 | 98 | −0.61 |
TMEM9B | TMEM9 domain family, member B | −1.72 | 85 | −0.62 |
YTHDF2 | YTH domain family, member 2 | −2.3 | 99 | −0.64 |
